Cargando…
The Acid Ceramidase Is a SARS-CoV-2 Host Factor
SARS-CoV-2 variants such as the delta or omicron variants, with higher transmission rates, accelerated the global COVID-19 pandemic. Thus, novel therapeutic strategies need to be deployed. The inhibition of acid sphingomyelinase (ASM), interfering with viral entry by fluoxetine was reported. Here, w...
Autores principales: | Geiger, Nina, Kersting, Louise, Schlegel, Jan, Stelz, Linda, Fähr, Sofie, Diesendorf, Viktoria, Roll, Valeria, Sostmann, Marie, König, Eva-Maria, Reinhard, Sebastian, Brenner, Daniela, Schneider-Schaulies, Sibylle, Sauer, Markus, Seibel, Jürgen, Bodem, Jochen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406565/ https://www.ncbi.nlm.nih.gov/pubmed/36010608 http://dx.doi.org/10.3390/cells11162532 |
Ejemplares similares
-
Azido-Ceramides, a Tool to Analyse SARS-CoV-2 Replication and Inhibition—SARS-CoV-2 Is Inhibited by Ceramides
por: Brenner, Daniela, et al.
Publicado: (2023) -
Drug-induced phospholipidosis is not correlated with the inhibition of SARS-CoV-2 - inhibition of SARS-CoV-2 is cell line-specific
por: Diesendorf, Viktoria, et al.
Publicado: (2023) -
Acetylsalicylic Acid and Salicylic Acid Inhibit SARS-CoV-2 Replication in Precision-Cut Lung Slices
por: Geiger, Nina, et al.
Publicado: (2022) -
Cell Type-Specific Anti-Viral Effects of Novel SARS-CoV-2 Main Protease Inhibitors
por: Geiger, Nina, et al.
Publicado: (2023) -
Editorial: Sphingolipids in Infection Control
por: Seibel, Jürgen, et al.
Publicado: (2021)